The abstract will be structured in single headings: Introduction, Material and Methods, Results and Conclusion.
Each paper must not exceed 400 words, NO figures, tables and references will be accepted in the body of the abstract.
Only JPG files, up to 500KB, for X Ray, CT scan, NMR, pictures of skin, fingers and so on can be uploaded, following the relative instructions after the body of the abstract.
SUBMISSION IS CLOSED
For information please contact: email@example.com
Monday, September 23, 2019 extended to Monday, September 30, 2019
Early bird registration fee: Monday, December 2, 2019
Notification to Authors: Friday, December 20, 2019
Encore abstracts are admitted but it is not allowed to submit the very same abstract presented elsewhere. It is important to have at least a new aspect and/or analysis within more data or emphasis on different/additional interpretation.
INSTRUCTIONS TO AUTHORS
The corresponding author is responsible for the abstract. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. The corresponding author can be a first author or not.
When the Scientific Committee will have evaluated all the received papers, the abstracts correspondents will receive all the information and necessary elements by mail.
Accepted abstracts will be published on the “JSRD – Journal of Scleroderma and Related Disorders”.
Each abstract will be published as submitted. The organizers do not accept any responsibility for the accuracy of the abstracts.
- 1. Pathogenesis (Autoantibodies)
- 2. Pulmonary including Interstitial Lung Disease and Pulmonary
- 3. Arterial Hypertension
- 4. Cardiac
- 5. Outcomes, Quality of Life, Psychological & Social
- 6. Imaging
- 7. Vascular
- 8. Renal
- 9. Musculoskeletal System & Rehabilitation
- 10. Gastrointestinal/Nutrition
- 11. Gender Related Issues
- 12. Recent Advances in Therapy (case series for new treatment)
- 13. Pediatric Scleroderma
- 14. Sclerosing skin diseases (Localized scleroderma)
- 15. Emerging therapies (pre-clinical)
- 16. Case reports
For information about abstract submission please contact:
AIM Group International – Rome office
Via Flaminia 1068 – 00189 Rome, Italy
Tel. +39 06 33053.1 – Fax +39 06 33053.249 – E-mail: firstname.lastname@example.org